Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

Karina Dahl Steffensen; Rikke Fredslund Andersen; Anders Jakobsen

Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

Karina Dahl Steffensen, Rikke Fredslund Andersen, Anders Jakobsen

Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review

Original language	Danish
Publication date	4. Jun 2018
Publication status	Published - 4. Jun 2018
Event	2018 ASCO Annual Meeting: Delivering discoveries: Expanding the reach of precision medicine - McCormick Place, Chicago , United States Duration: 1. Jun 2018 → 5. Jun 2018 https://am.asco.org

Conference

Conference	2018 ASCO Annual Meeting
Location	McCormick Place
Country/Territory	United States
City	Chicago
Period	01/06/2018 → 05/06/2018
Internet address	https://am.asco.org

Documents & Links

https://meetinglibrary.asco.org/record/163523/abstract

Methyleret gen afslører effekt af PARP-hæmmere
Dahl Steffensen, K.
06/06/2018
1 item of Media coverage
Press/Media: Press / Media

Cite this

@conference{9ec1de1aad954fada775ecca16b33e8b,

title = "Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.",

author = "{Dahl Steffensen}, Karina and {Fredslund Andersen}, Rikke and Anders Jakobsen",

note = "J Clin Oncol 36, 2018 (suppl; abstr 5540); 2018 ASCO Annual Meeting : Delivering discoveries: Expanding the reach of precision medicine ; Conference date: 01-06-2018 Through 05-06-2018",

year = "2018",

month = jun,

day = "4",

language = "Dansk",

url = "https://am.asco.org",

}

Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients. / Dahl Steffensen, Karina ; Fredslund Andersen, Rikke; Jakobsen, Anders.
2018. Poster session presented at 2018 ASCO Annual Meeting, Chicago , Illinois, United States.

Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review

TY - CONF

T1 - Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

AU - Dahl Steffensen, Karina

AU - Fredslund Andersen, Rikke

AU - Jakobsen, Anders

N1 - J Clin Oncol 36, 2018 (suppl; abstr 5540)

PY - 2018/6/4

Y1 - 2018/6/4

M3 - Poster

T2 - 2018 ASCO Annual Meeting

Y2 - 1 June 2018 through 5 June 2018

ER -

Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

Conference

Documents & Links

Related Press/Media

Methyleret gen afslører effekt af PARP-hæmmere

Cite this